DrugPatentWatch Database Preview
CYSVIEW KIT Drug Profile
Which patents cover Cysview Kit, and when can generic versions of Cysview Kit launch?
Cysview Kit is a drug marketed by Photocure Asa and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in CYSVIEW KIT is hexaminolevulinate hydrochloride. One supplier is listed for this compound. Additional details are available on the hexaminolevulinate hydrochloride profile page.
Summary for CYSVIEW KIT
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 42 |
| Clinical Trials: | 2 |
| Patent Applications: | 17 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CYSVIEW KIT |
| DailyMed Link: | CYSVIEW KIT at DailyMed |
Generic Entry Opportunity Date for CYSVIEW KIT
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for CYSVIEW KIT
| 140898-91-5 |
| 5-amino-4-oxopentanoic acid hexyl ester hydrochloride |
| 5-Aminolevulinic acid hexyl ester hydrochloride |
| 5-Aminolevulinic acid hexylester hydrochloride |
| 6842AA |
| 898A915 |
| A-6140 |
| AC1O5FJ4 |
| AK-59194 |
| AKOS016002051 |
| ala hexyl ester hydrochloride |
| AM84373 |
| aminolevulinc acid hexyl ester |
| aminolevulinic acid hexyl ester hydrochloride |
| AN-31604 |
| ANW-58882 |
| AX8102340 |
| C11H22ClNO3 |
| CHEMBL1201785 |
| CS-5206 |
| CTK8B7894 |
| Cysview |
| Cysview (TN) |
| D04436 |
| D0AY9Q |
| D4F329SL1O |
| DB-063352 |
| delta-aminolevulinic acid hexyl ester hydrochloride |
| DTXSID80161486 |
| FT-0767765 |
| Hexaminolevulinate (hydrochloride) |
| hexaminolevulinate HCl |
| Hexaminolevulinate Hydrochloride |
| Hexaminolevulinate hydrochloride (USAN) |
| Hexaminolevulinate Hydrochloride [USAN] |
| Hexaminolevulinate hydrochloride, >=98% (HPLC) |
| HexvisR |
| Hexvix |
| Hexvix (TN) |
| hexyl 5-amino-4-oxo-pentanoate hydrochloride |
| Hexyl 5-amino-4-oxopentanoate hydrochloride |
| hexyl aminolevulinate |
| HY-16045 |
| LZYXPFZBAZTOCH-UHFFFAOYSA-N |
| MFCD03695491 |
| MolPort-016-582-410 |
| n-hexyl 5-aminolevulinate hydrochloride |
| OR1924 |
| P 1206 |
| P-1026 |
| P-1206 |
| Pentanoic acid, 5-amino-4-oxo-, hexyl ester, hydrochloride |
| SCHEMBL937621 |
| TC-147627 |
| UNII-D4F329SL1O |
| ZX-AT022126 |
US Patents and Regulatory Information for CYSVIEW KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for CYSVIEW KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ➤ Sign Up | ➤ Sign Up |
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ➤ Sign Up | ➤ Sign Up |
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
